80 percent of Ebola survivors suffer disabilities one year after discharge

August 21, 2017, University of Liverpool
Ebola survivor and medical team at her discharge ceremony from the Ebola Treat Unit 34th Regiment Military Hospital Freetown, Sierra Leone on Feb. 5, 2016. Credit: MG Semple

New research, conducted by the University of Liverpool and Liverpool School of Tropical Medicine, highlights the need for long-term rehabilitation of Ebola survivors after almost 80% of those interviewed were found to have major limitations in mobility, cognition and vision.

The scale of the 2014-2016 West African Ebola outbreak has resulted in an unprecedented number of survivors and the opportunity to vastly improve the understanding of the health challenges they face.

Researchers, led by Soushieta Jagadesh, assessed disability amongst a cohort of Ebola Virus Disease (EVD) survivors 12 months following their discharge from the Ebola Survivors Clinic, 34 Military Hospital (MH34) in Freetown, Sierra Leone and compared with their close contacts.

Twenty-seven EVD survivors and 54 unaffected contacts were recruited.

Physical and mental impairments

Disability was measured using the Washington Group-Disability Extended Questionnaire (WG ES-F) for both the EVD survivors and their non-affected contacts. The questionnaire measured self-reported physical and mental impairments present at the time of the interview.

The questionnaire assessed six domains: vision, hearing, mobility, self-care, communication and cognition. Functionality scores were calculated from the severity and frequency of anxiety, depression, pain and fatigability.

Disability in at least one of the six domains was reported by significantly more EVD survivors than controls.

Mobility

Disability was reported by 78% of EVD survivors compared to 11% of non survivors.

Differences in physical disability were most marked with the EVD survivors' cohort being between up to 206 times more likely to experience difficulty in walking 100m, 500m, climbing 12 stairs or overall moderate difficulty with mobility. Pain, fatigue, anxiety and depression all influence disability in mobility.

Relative to controls the EVD survivors had very significantly increased mean pain scores, fatigue scores, anxiety scores and depression scores.

The study also showed that EVD survivors had significantly higher subjective difficulties remembering or concentrating and were eight times more likely than controls to suffer from blurred vision.

Future care

Dr Soushieta Jagadesh, said: "We have demonstrated that a year following acute disease, survivors of the West African EVD outbreak continue to have a higher chance of disability in mobility, cognition and vision than their close-contacts. Issues such as anxiety and depression persist in EVD survivors and must not be neglected."

Dr Janet Scott, Clinical Lecturer, University of Liverpool, said: "This study highlights that EVD results in long term substantial disability. Understanding post Ebola syndrome could improve our future care of EVD patients and patients suffering the sequelae of other severe viral infections."

Rehabilitation

Dr Ralf Weigal, Senior Clinical Lecturer, Liverpool School of Tropical Medicine, said: "Further evaluation of the scale of disability in larger survivor cohorts would be useful, as is a new focus on sustainable long-term rehabilitation in EVD survivors."

Dr Sesay, Clinical Lead EVD Survivors Clinic, MH34, commented: "We continue to care for over 500 Ebola Survivors, as part of the country wide integrated network of EVD Survivors Care. This study highlights the continuing need for focused care for EVD survivors."

Explore further: Novel retinal lesion seen in some ebola survivors

More information: Soushieta Jagadesh et al, Disability among Ebola survivors and their close contacts in Sierra Leone: a retrospective case-controlled cohort study., Clinical Infectious Diseases (2017). DOI: 10.1093/cid/cix705

Related Stories

Novel retinal lesion seen in some ebola survivors

June 15, 2017
(HealthDay)—A small percentage of Ebola virus disease (EVD) survivors have a novel retinal lesion, according to research published in the July issue of the U.S. Centers for Disease Control and Prevention's Emerging Infectious ...

Ebola survivors have a 'unique' retinal scar

May 15, 2017
Researchers from the University of Liverpool have conducted a study of Ebola survivors to determine if the virus has any specific effects on the back on the eye using an ultra widefield retinal camera.

Cerebrospinal fluid of survivors of Ebola virus disease examined

July 17, 2017
A new research letter published by JAMA Neurology reports on examinations of cerebrospinal fluid collected from survivors of Ebola virus disease (EVD) to investigate potential Ebola virus persistence in the central nervous ...

Ebola detected in semen of survivors two years after infection

August 2, 2017
Ebola virus RNA can persist in the semen of survivors more than two years after the onset of infection researchers at the University of North Carolina at Chapel Hill have found. The research team, which included investigators ...

Stroke survivors and their carers often have poor mental health

July 28, 2017
Recent research has shed light on how stroke impacts not only a person's physical health and well-being, but also their social and mental health. While this may not be surprising, the simultaneous decrease in mental health ...

Vision impairment and eye diseases continue to be concerns for Ebola survivors

January 16, 2017
The acute outbreak of Ebola virus disease (EVD) has subsided in West Africa, but the medical community continues to learn about long-term complications for survivors – including the potential for blinding eye disease. One ...

Recommended for you

Surgery unnecessary for many prostate cancer patients

December 13, 2018
Otherwise healthy men with advanced prostate cancer may benefit greatly from surgery, but many with this diagnosis have no need for it. These conclusions were reached by researchers after following a large group of Scandinavian ...

Combining three treatment strategies may significantly improve melanoma treatment

December 12, 2018
A study by a team led by a Massachusetts General Hospital (MGH) investigator finds evidence that combining three advanced treatment strategies for malignant melanoma—molecular targeted therapy, immune checkpoint blockade ...

An integrated approach to finding new treatments for breast cancer

December 12, 2018
Unraveling the complexity of cancer biology can lead to the identification new molecules involved in breast cancer and prompt new avenues for drug development. And proteogenomics, an integrated, multipronged approach, seems ...

Lethal combination: Drug cocktail turns off the juice to cancer cells

December 12, 2018
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth—this was discovered by researchers from the University of Basel's Biozentrum two years ago. In a follow-up study, ...

Researchers use computer model to predict prostate cancer progression

December 12, 2018
An international team of cancer researchers from Denmark and Germany have used cancer patient data to develop a computer model that can predict the progression of prostate cancer. The model is currently being implemented ...

New insight into stem cell behaviour highlights therapeutic target for cancer treatment

December 12, 2018
Research led by the University of Plymouth and Technische Universität Dresden has identified a new therapeutic target for cancer treatment and tissue regeneration – a protein called Prominin-1.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.